11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop

Genes Chromosomes and Cancer

Volumn 33, Issue 4, 2002, Pages 362-378

  Bloomfield, Clara D ^a   Archer, Kellie J ^a   Mrózek, Krzysztof ^a   Lillington, Debra M ^b   Kaneko, Yasuhiko ^c   Head, David R ^d   Dal Cin, Paola ^e   Raimondi, Susana C ^f  

^a OHIO STATE UNIVERSITY   (United States)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c SAITAMA CANCER CENTER   (Japan)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL RESEARCH; CONFERENCE PAPER; CONTROLLED STUDY; COVARIANCE; FEMALE; HUMAN; KARYOTYPE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SURVIVAL;

EID: 0036197783     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10046     Document Type: Conference Paper

References (52)

1. Implication of prior treatment with drug combinations including inhibitors of topoisomerase 11 in therapy-related monocytic leukemia with a 9;11 translocation
2. Acute myeloid leukemia with t(6;9)(p23;q34): Association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype
3. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements
4. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase 11 inhibitors, an increasing problem: Report on two new cases and review of the literature since 1992
5. Long-term survival of patients with acute myeloid leukemia: A third follow-up of the Fourth International Workshop on chromosomes in leukemia
6. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
7. Chronic myelomonocytic leukemia with t(13;14) in a child
8. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial
9. Patients with t(8;21)(q22;q22) and acute mycloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
10. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes
11. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)
12. Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities
13. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II
14. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
15. Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia
16. New translocations in chronic granulocytic leukaemia: t(X;22)(p22;q11) and t(15;22)(q26;q11)
17. Secondary chromosomal abnormalities in acute leukemias
18. Hematologic malignancies with t(4;11)(q21;q23) - A cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases
19. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: Report from an International Workshop
20. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
21. The t(6;11)(q27;q23) translocation in acute leukemia: A laboratory and clinical study of 30 cases
22. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival
23. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia
24. The translocations, t(11;19)(q23;p13.1) and t(11; 19)(q23;p13.3): A cytogenetic and clinical profile of 53 patients
25. Inversion of chromosome 5 long arm in region of cell growth gene cluster in hematologic disorders
26. Adult patients with de novo acute myeloid leukemia and t(9:11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B study
27. Clinical importance of cytogenetics in acute myeloid leukaemia
28. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia
29. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: The Eastern Cooperative Oncology Group experience
30. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation
31. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia
32. Chromosomes in acute leukemia
33. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia
34. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse
35. Epipodophyllotoxin-related acute myeloid leukemia: A study of 35 cases
36. Prognostic factors in infants with acute myeloid leukemia
37. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia
38. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study - POG 8821
39. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung
40. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): A report of two cases
41. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report
42. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy
43. Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities
44. 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia
45. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study
46. Hematological malignancies with t(9;11)(p21-22;q23) - A laboratory and clinical study of 125 cases
47. All-trans-retinoic acid in acute promyelocytic leukemia
48. A new chromosome anomaly in acute lymphoblastic leukemia (ALL)
49. Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: Report on two new cases and review of the literature
50. All patients with acute nonlymphocytic leukemia may have a chromosomal defect